- Home
- AXSM vs THG Comparison
AXSM vs THG Comparison
Compare AXSM & THG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- THG
- Stock Information
- Founded
- AXSM 2012
- THG 1852
- Country
- AXSM United States
- THG United States
- Employees
- AXSM N/A
- THG N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- THG Property-Casualty Insurers
- Sector
- AXSM Health Care
- THG Finance
- Exchange
- AXSM Nasdaq
- THG Nasdaq
- Market Cap
- AXSM 5.9B
- THG 6.3B
- IPO Year
- AXSM 2015
- THG 1995
- Fundamental
- Price
- AXSM $135.51
- THG $170.91
- Analyst Decision
- AXSM Strong Buy
- THG Buy
- Analyst Count
- AXSM 19
- THG 8
- Target Price
- AXSM $174.47
- THG $185.75
- AVG Volume (30 Days)
- AXSM 501.4K
- THG 226.9K
- Earning Date
- AXSM 11-03-2025
- THG 10-29-2025
- Dividend Yield
- AXSM N/A
- THG 2.11%
- EPS Growth
- AXSM N/A
- THG 73.14
- EPS
- AXSM N/A
- THG 17.31
- Revenue
- AXSM $561,263,000.00
- THG $6,506,900,000.00
- Revenue This Year
- AXSM $63.66
- THG $4.34
- Revenue Next Year
- AXSM $54.46
- THG $5.90
- P/E Ratio
- AXSM N/A
- THG $9.86
- Revenue Growth
- AXSM 65.83
- THG 5.26
- 52 Week Low
- AXSM $75.56
- THG $145.17
- 52 Week High
- AXSM $139.13
- THG $186.46
- Technical
- Relative Strength Index (RSI)
- AXSM 67.09
- THG 42.40
- Support Level
- AXSM $129.45
- THG $167.44
- Resistance Level
- AXSM $136.13
- THG $173.18
- Average True Range (ATR)
- AXSM 5.45
- THG 3.26
- MACD
- AXSM 0.43
- THG -0.44
- Stochastic Oscillator
- AXSM 84.66
- THG 38.10
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About THG Hanover Insurance Group Inc
The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.